Related Experiment Video
Updated: May 19, 2026

A Novel Bayesian Change-point Algorithm for Genome-wide Analysis of Diverse ChIPseq Data Types
Published on: December 10, 2012
Knowledge-guided Bayesian biclustering model for omics data with noisy graphs
Qiyiwen Zhang1, Wenrui Li2, Suprateek Kundu3
1Department of Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, United States.
Abstract:
Extracting biologically meaningful information from high-dimensional, heterogeneous omics data is one of the key challenges in many biomedical studies. Among various biomedical applications, disease subtyping is of particular interest due to its critical role in improving diagnosis and designing personalized treatments. To address this, biclustering has become a widely used statistical method for subtyping. Additionally, it has been demonstrated across various statistical learning methods that incorporating biological graph knowledge such as gene regulatory network can significantly enhance variable selection, prediction accuracy, and model interpretability. However, existing graph-guided methods, while often yielding promising results, tend to overlook potential misspecifications, such as false positive (FP) and false negative (FN) edges in the graphs. Ignoring this noise can lead to suboptimal identification of biclusters. Therefore, it is essential to develop biclustering methods that can effectively handle noisy graphs as well as provide biological insight. We propose a Bayesian denoising knowledge-guided biclustering method that enables to integrate multiple graphs simultaneously. The incorporated graphs, viewed as noisy variations of the underlying true graph, are de-noised through modeling of FP and FN errors. A Markov chain Monte Carlo algorithm is developed to estimate the biclusters. Extensive simulation studies and real data analyses, including gene expression and proteomics datasets of Alzheimer's disease, have been conducted to validate the superior performance of the proposed method.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Biostatistics: Overview
Discrete variables are...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Statistical Methods for Analyzing Epidemiological Data
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...
Overview of Biostatistics in Health Sciences
